These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 3501565)
1. Altered antibody isotype in cystic fibrosis: impaired natural antibody response to polysaccharide antigens. Moss RB; Hsu YP; Van Eede PH; Van Leeuwen AM; Lewiston NJ; De Lange G Pediatr Res; 1987 Dec; 22(6):708-13. PubMed ID: 3501565 [TBL] [Abstract][Full Text] [Related]
2. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children. Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905 [TBL] [Abstract][Full Text] [Related]
3. Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine. Granoff DM; Shackelford PG; Suarez BK; Nahm MH; Cates KL; Murphy TV; Karasic R; Osterholm MT; Pandey JP; Daum RS N Engl J Med; 1986 Dec; 315(25):1584-90. PubMed ID: 3491315 [TBL] [Abstract][Full Text] [Related]
4. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. Umetsu DT; Ambrosino DM; Quinti I; Siber GR; Geha RS N Engl J Med; 1985 Nov; 313(20):1247-51. PubMed ID: 3877240 [TBL] [Abstract][Full Text] [Related]
5. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera. Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588 [TBL] [Abstract][Full Text] [Related]
6. Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae. Weinberg GA; Granoff DM; Nahm MH; Shackelford PG J Immunol; 1986 Jun; 136(11):4232-6. PubMed ID: 3486228 [TBL] [Abstract][Full Text] [Related]
8. Altered antibody isotype in cystic fibrosis: possible role in opsonic deficiency. Moss RB; Hsu YP; Sullivan MM; Lewiston NJ Pediatr Res; 1986 May; 20(5):453-9. PubMed ID: 3714355 [TBL] [Abstract][Full Text] [Related]
9. In vitro human antibody production to the Haemophilus influenzae type b capsular polysaccharide. Munoz JL; Insel RA J Immunol; 1987 Sep; 139(6):2026-31. PubMed ID: 3040862 [TBL] [Abstract][Full Text] [Related]
10. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. Ambrosino DM; Schiffman G; Gotschlich EC; Schur PH; Rosenberg GA; DeLange GG; van Loghem E; Siber GR J Clin Invest; 1985 Jun; 75(6):1935-42. PubMed ID: 3924957 [TBL] [Abstract][Full Text] [Related]
11. IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine. Granoff DM; Weinberg GA; Shackelford PG Pediatr Res; 1988 Aug; 24(2):180-5. PubMed ID: 3263612 [TBL] [Abstract][Full Text] [Related]
12. Expression of crossreactive idiotypes by human antibodies specific for the capsular polysaccharide of Hemophilus influenzae B. Lucas AH J Clin Invest; 1988 Feb; 81(2):480-6. PubMed ID: 3257499 [TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Miller MA; Meschievitz CK; Ballanco GA; Daum RS Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population. Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066 [TBL] [Abstract][Full Text] [Related]
16. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine. Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736 [TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide. Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264 [TBL] [Abstract][Full Text] [Related]
18. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines. Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735 [TBL] [Abstract][Full Text] [Related]
19. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses. Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330 [TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants. Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]